About site:

Domain name - abacavir.de

Site title - Site Title Unavailable

Go to website - Link to abacavir.de was blocked

Site Logo

IP address:

49.13.50.5

Domain name servers:

ns1.redirectdom.com ns2.redirectdom.com

All records:

☆ abacavir.de. 3600 IN NS ns1.redirectdom.com.
☆ abacavir.de. 3600 IN NS ns2.redirectdom.com.
☆ abacavir.de. 3600 IN A 49.13.50.5
☆ abacavir.de. 3600 IN SOA ns1.redirectdom.com. dnsmaster.ns1.redirectdom.com. 2024061402 10800 3600 604800 3600

%
% Terms and Conditions of Use
%
% The above data may only be used within the scope of technical or
% administrative necessities of Internet operation or to remedy legal
% problems.
% The use for other purposes, in particular for advertising, is not permitted.
%
% The DENIC whois service on port 43 doesn't disclose any information concerning
% the domain holder, general request and abuse contact.
% This information can be obtained through use of our web-based whois service
% available at the DENIC website:
% http://www.denic.de/en/domains/whois-service/web-whois.html
%
%

Domain: abacavir.de
Nserver: ns1.redirectdom.com
Nserver: ns2.redirectdom.com
Status: connect
Changed: 2024-06-14T07:33:48+02:00

Brief facts about abacavir:

Abacavir, sold under the brand name Ziagen among others, is a medication used to treat HIV/AIDS. Similar to other nucleoside analog reverse-transcriptase inhibitors, abacavir is used together with other HIV medications, and is not recommended by itself. It is taken by mouth as a tablet or solution and may be used in children over the age of three months. Abacavir is generally well tolerated. Common side effects include vomiting, insomnia, fever, and feeling tired. Other common side effects include loss of appetite, headache, nausea, diarrhea, rash, and lethargy. More severe side effects include hypersensitivity, liver damage, and lactic acidosis. Genetic testing can indicate whether a person is at higher risk of developing hypersensitivity. Symptoms of hypersensitivity include rash, vomiting, and shortness of breath. Abacavir is in the NRTI class of medications, which work by blocking reverse transcriptase, an enzyme needed for HIV virus replication.

Nucleoside analog reverse transcriptase inhibitors

Purines

World Health Organization essential medicines